1
|
Parentelli AS, Picard C, Boursier G, Melki I, Belot A, Smahi A, Georgin-Lavialle S. [Autoinflammatory diseases associated with RIPK1 mutations: A review of the literature]. Rev Med Interne 2022; 43:552-558. [PMID: 35786329 DOI: 10.1016/j.revmed.2022.06.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2022] [Accepted: 06/12/2022] [Indexed: 11/19/2022]
Abstract
Autoinflammatory diseases related to RIPK1 mutations have been recently described. Two distinct clinical phenotypes have been reported and depend on the type and location of the mutation. When the mutation is recessive with loss of function, patients develop a combined phenotype of immune deficiency with recurrent bacterial and fungal infections and signs of early inflammatory bowel disease, non-erosive polyarthritis and growth retardation. On the other hand, when the mutation is dominant, gain of function, the manifestations are only auto-inflammatory with extensive lymphoproliferation, oral lesions such as aphthosis or ulcers, abdominal pain and hepatosplenomegaly. The mutations described for the dominant form affect only the cleavage site of caspase 8 and the clinical phenotype is called CRIA for Cleavage-Resistant RIPK1-Induced Autoinflammatory syndrome. The recessive form is severe and life-threatening requiring hematopoietic stem cell transplantation while the dominant form responds well to interleukin-6 receptor antagonists. Thus, RIPK1 mutations can induce various clinical manifestations with two distinct phenotypes. Although still rare, because of their recent description, these diseases can be suspected by an internist, in front of recurrent digestive features and will be increasingly diagnosed in the future through the integration of this gene in the diagnostic chips dedicated to autoinflammatory diseases and early inflammatory bowel diseases, using next generation sequencing.
Collapse
Affiliation(s)
- A S Parentelli
- Service des urgences pédiatriques, hôpital Robert-Debré, Assistance Publique des hôpitaux de Paris (AP-HP), 48, boulevard Sérurier, 75019 Paris, France; Institut Imagine, Inserm U1163, CNRS ERL 8254, université Paris Cité, Sorbonne Paris-Cité, Laboratoire d'excellence GR-Ex, Paris, France
| | - C Picard
- Centre d'études des déficits immunitaires (CEDI), département médico-universitaire BioPhyGen, hôpital Necker enfants malades, AP-HP, 149, rue de Sèvres, 75743 Paris Cedex 15, France; Université Paris Cité, Paris, France; Laboratoire d'Activation des Lymphocytes et Susceptibilité au virus EBV, Inserm UMR 1163, Institut Imagine, Paris, France; Centre de référence des déficits immunitaires héréditaires (CEREDIH), hôpital Necker-Enfants Malades, AP-HP, 149, rue de Sèvres, 75743 Paris Cedex 15, France
| | - G Boursier
- Laboratoire de génétique des maladies rares et auto-inflammatoires, service de génétique moléculaire et cytogénomique, CHU de Montpellier, Université de Montpellier, 371, avenue du Doyen Gaston-Giraud, 34295 Montpellier Cedex 5, France; Centre de référence des maladies Auto-Inflammatoires rares et de l'Amylose Inflammatoire (CEREMAIA), hôpital de Tenon, AP-HP, 75020 Paris, France
| | - I Melki
- Service de pédiatrie générale, maladies infectieuses et médecine interne pédiatrique, hôpital Robert-Debré, AP-HP, 48, boulevard Sérurier, 75019 Paris, France; Centre de référence des rhumatismes et auto-immunité systémique de l'enfant (RAISE), hôpital Necker Enfants Malades, AP-HP, 149, rue de Sèvres, 75743 Paris Cedex 15, France
| | - A Belot
- CIRI, Inserm U1111, service de néphrologie, rhumatologie, dermatologie pédiatrique, hôpital Femme-Mère-Enfant, hospices civils de Lyon, université de Lyon 1, 69677 Bron, France; Centre de référence des rhumatismes et auto-immunité systémique de l'enfant (RAISE), hôpital Necker Enfants Malades, AP-HP, 149, rue de Sèvres, 75743 Paris Cedex 15, France
| | - A Smahi
- Institut Imagine, Inserm U1163, CNRS ERL 8254, université Paris Cité, Sorbonne Paris-Cité, Laboratoire d'excellence GR-Ex, Paris, France
| | - S Georgin-Lavialle
- Département de médecine interne, DHUI2B, département hospitalo-universitaire inflammation, immunopathologie, biothérapie, hôpital Tenon, université Paris 6, Pierre et Marie Curie, AP-HP, 4, rue de la Chine, 75020 Paris, France; Centre de référence des maladies Auto-Inflammatoires rares et de l'Amylose Inflammatoire (CEREMAIA), hôpital de Tenon, AP-HP, 75020 Paris, France.
| |
Collapse
|
2
|
Sbidian E, Madrange M, Viguier M, Salmona M, Duchatelet S, Hovnanian A, Smahi A, Le Goff J, Bachelez H. Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds. Br J Dermatol 2019; 181:1304-1306. [PMID: 31150103 PMCID: PMC7161746 DOI: 10.1111/bjd.18203] [Citation(s) in RCA: 39] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- E Sbidian
- AP-HP, Hôpitaux Universitaires Henri Mondor, Département de Dermatologie, UPEC, Créteil, F-94010, France.,Inserm, Centre d'Investigation Clinique 1430, Créteil, F-94010, France.,EA 7379 EpidermE, Université Paris-Est Créteil, UPEC, Créteil, F-94010, France
| | - M Madrange
- Laboratoire de Génétique des Maladies Autoinflammatoires, INSERM UMR 1163, Institut Imagine, Hôpital Necker, Paris, France
| | - M Viguier
- Université Reims-Champagne Ardenne, Service de Dermatologie-Vénéréologie, Hôpital Robert Debré, Reims, France
| | - M Salmona
- Sorbonne Paris Cité Université Paris Diderot, Paris, France.,Department of Virology, AP-HP, Hôpital Saint-Louis, Paris, F-75010, France.,Inserm INSIGHT U976, AP-HP, Hôpital Saint-Louis, Paris, F-75010, France
| | - S Duchatelet
- Laboratoire de Génétique des Maladies Cutanées, INSERM UMR 1163, Institut Imagine, Hôpital Necker, Paris, France
| | - A Hovnanian
- Laboratoire de Génétique des Maladies Cutanées, INSERM UMR 1163, Institut Imagine, Hôpital Necker, Paris, France
| | - A Smahi
- Laboratoire de Génétique des Maladies Autoinflammatoires, INSERM UMR 1163, Institut Imagine, Hôpital Necker, Paris, France
| | - J Le Goff
- Sorbonne Paris Cité Université Paris Diderot, Paris, France.,Department of Virology, AP-HP, Hôpital Saint-Louis, Paris, F-75010, France.,Inserm INSIGHT U976, AP-HP, Hôpital Saint-Louis, Paris, F-75010, France
| | - H Bachelez
- Laboratoire de Génétique des Maladies Autoinflammatoires, INSERM UMR 1163, Institut Imagine, Hôpital Necker, Paris, France.,Laboratoire de Génétique des Maladies Cutanées, INSERM UMR 1163, Institut Imagine, Hôpital Necker, Paris, France.,Department of Dermatology, AP-HP, Hôpital Saint-Louis, 1, avenue Claude Vellefaux., 75475, Paris cedex 10, France
| |
Collapse
|
3
|
Gottlieb J, Madrange M, Gardair C, Sbidian E, Frazier A, Wolkenstein P, Hickman G, Schneider P, Baudry C, Claudepierre P, Bertheau P, Richette P, Smahi A, Bachelez H. PAPASH
, Ps
APASH
and
PASS
autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens. Br J Dermatol 2019; 181:866-869. [DOI: 10.1111/bjd.18003] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- J. Gottlieb
- Department of Dermatology APHP Hôpital St‐Louis Paris France
| | - M. Madrange
- UMR Inserm 1163 Laboratoire de Génétique des Maladies Cutanées Institut Imagine, Necker Hospital Paris France
| | - C. Gardair
- Department of Pathology APHP Hôpital St‐Louis Paris France
- Department of Gastroenterology APHP Hôpital St‐Louis Paris France
| | - E. Sbidian
- Sorbonne Paris Cité Université Paris Diderot Paris France
- Department of Dermatology APHP Hôpital Henri MondorCréteil
- Department of Rheumatology APHP Hôpital Henri Mondor Créteil
| | - A. Frazier
- Université Paris Est Créteil Créteil France
| | - P. Wolkenstein
- Sorbonne Paris Cité Université Paris Diderot Paris France
- Department of Dermatology APHP Hôpital Henri MondorCréteil
- Department of Rheumatology APHP Hôpital Henri Mondor Créteil
| | - G. Hickman
- Department of Dermatology APHP Hôpital St‐Louis Paris France
| | - P. Schneider
- Department of Dermatology APHP Hôpital St‐Louis Paris France
| | - C. Baudry
- Department of Gastroenterology APHP Hôpital St‐Louis Paris France
- EA 7379 – EpidermE Créteil France
| | - P. Claudepierre
- Department of Dermatology APHP Hôpital Henri MondorCréteil
- Department of Rheumatology APHP Hôpital Henri Mondor Créteil
- Department of Rheumatology APHP Hôpital Lariboisière, Paris, France APHP Hôpital Henri Mondor Créteil France
| | - P. Bertheau
- Department of Pathology APHP Hôpital St‐Louis Paris France
- Department of Gastroenterology APHP Hôpital St‐Louis Paris France
| | - P. Richette
- Université Paris Est Créteil Créteil France
- Inserm U1132, UFR de médecine Paris Diderot University Paris France
| | - A. Smahi
- UMR Inserm 1163 Laboratoire de Génétique des Maladies Cutanées Institut Imagine, Necker Hospital Paris France
| | - H. Bachelez
- Department of Dermatology APHP Hôpital St‐Louis Paris France
- UMR Inserm 1163 Laboratoire de Génétique des Maladies Cutanées Institut Imagine, Necker Hospital Paris France
- Department of Gastroenterology APHP Hôpital St‐Louis Paris France
| |
Collapse
|
4
|
Polivka L, Hadj-Rabia S, Bal E, Leclerc-Mercier S, Madrange M, Smahi A, Bodemer C. Syndrome SAMEC : un modèle d’interaction dysfonction de la barrière épithéliale-dysrégulation immunologique. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
5
|
Ennouri M, Bahloul E, Ammar R, Smahi A, Marrakchi S, Turki H, Bougacha N. Prévalence de la mutation p.L27P du gène IL36RN dans le psoriasis dans le sud tunisien : hétérogénéité génétique. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
6
|
Gottlieb J, Madrange M, Sbidian E, Frazier A, Wolkenstein P, Hickman G, Schneider P, Claudepierre P, Baudry C, Gardair C, Bertheau P, Richette P, Smahi A, Bachelez H. Syndromes PAPASH, PsAPASH et PASS : hétérogénéité phénotypique, signature biologique commune, intérêt des thérapeutiques immunosuppressives. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
7
|
Cluzeau C, Marrakchi S, Picard C, Munnich A, Smahi A, Turki H. First homozygous large deletion in EDARADD
gene associated with a severe form of anhidrotic ectodermal dysplasia. J Eur Acad Dermatol Venereol 2018; 33:e55-e57. [DOI: 10.1111/jdv.15182] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Affiliation(s)
- C. Cluzeau
- Department of Genetics; Institut Imagine; Assistance Publique-Hôpitaux de Paris (AP-HP); Necker Hospital for Sick Children; INSERM UMR 1163; University Paris Descartes; Paris France
| | - S. Marrakchi
- Department of Dermatology; Hedi Chaker Hospital; Sfax Tunisia
| | - C. Picard
- Laboratory of Lymphocyte Activation and Susceptibility to EBV infection; Imagine Institut; University Paris Descartes; INSERM UMR 1163; Paris France
- Study Center for Primary Immunodeficiencies; AP-HP; Necker Hospital for Sick Children; Paris France
| | - A. Munnich
- Department of Genetics; Institut Imagine; Assistance Publique-Hôpitaux de Paris (AP-HP); Necker Hospital for Sick Children; INSERM UMR 1163; University Paris Descartes; Paris France
| | - A. Smahi
- Department of Genetics; Institut Imagine; Assistance Publique-Hôpitaux de Paris (AP-HP); Necker Hospital for Sick Children; INSERM UMR 1163; University Paris Descartes; Paris France
| | - H. Turki
- Department of Dermatology; Hedi Chaker Hospital; Sfax Tunisia
| |
Collapse
|
8
|
Park H, Chiticariu E, Bachmann D, Smahi A, Vabres P, Huber M, Hohl D. 205 ARP-T1 is a protein associated with a novel ciliopathy in inherited basal cell cancer of Bazex-Dupré-Christol Syndrome. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
9
|
Bal E, Belaid-Choucair Z, Kayserili H, Madrange M, Park H, Chiticariu E, Magnaldo T, Hohl D, Munnich A, Smahi A. 485 Mutations in ACTRT1 and its transcribed non-coding elements lead to aberrant activation of the Hedgehog signaling pathway in inherited and sporadic basal cell carcinomas. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.06.507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
10
|
Ferneiny M, Hadj-Rabia S, Regnier S, Ortonne N, Smahi A, Steffann J, Bonnefont JP, Fraitag S, Chosidow O, Bodemer C. Unique subungueal keratoacanthoma revealing incontinentia pigmenti. J Eur Acad Dermatol Venereol 2015; 30:1401-3. [DOI: 10.1111/jdv.13245] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- M. Ferneiny
- Reference center for genodermatoses and rare skin diseases (MAGEC); Department of Dermatology; Necker-Enfants Malades Hospital; Assistance Publique-Hôpitaux de Paris; Paris France
- Institut Imagine; Paris Descartes University - Sorbonne Paris Cité; Paris France
| | - S. Hadj-Rabia
- Reference center for genodermatoses and rare skin diseases (MAGEC); Department of Dermatology; Necker-Enfants Malades Hospital; Assistance Publique-Hôpitaux de Paris; Paris France
- Institut Imagine; Paris Descartes University - Sorbonne Paris Cité; Paris France
- INSERM U1163; Institut Imagine; Paris France
| | - S. Regnier
- Department of Dermatology; Henri Mondor Hospital; Assistance Publique-Hôpitaux de Paris; Créteil France
| | - N. Ortonne
- Department of Pathology; Hôpital Henri Mondor; Assistance Publique-Hôpitaux de Paris; Créteil France
| | - A. Smahi
- INSERM U1163; Institut Imagine; Paris France
| | - J. Steffann
- Institut Imagine; Paris Descartes University - Sorbonne Paris Cité; Paris France
- Molecular genetics laboratory; Necker-Enfants Malades Hospital; Assistance Publique- Hôpitaux de Paris; Paris France
| | - J.-P. Bonnefont
- Institut Imagine; Paris Descartes University - Sorbonne Paris Cité; Paris France
- Molecular genetics laboratory; Necker-Enfants Malades Hospital; Assistance Publique- Hôpitaux de Paris; Paris France
| | - S. Fraitag
- Reference center for genodermatoses and rare skin diseases (MAGEC); Department of Dermatology; Necker-Enfants Malades Hospital; Assistance Publique-Hôpitaux de Paris; Paris France
- Department of Pathology; Necker-Enfants-Malades Hospital; Assistance Publique-Hôpitaux de Paris; Paris France
| | - O. Chosidow
- Department of Dermatology; Henri Mondor Hospital; Assistance Publique-Hôpitaux de Paris; Créteil France
| | - C. Bodemer
- Reference center for genodermatoses and rare skin diseases (MAGEC); Department of Dermatology; Necker-Enfants Malades Hospital; Assistance Publique-Hôpitaux de Paris; Paris France
- Institut Imagine; Paris Descartes University - Sorbonne Paris Cité; Paris France
- INSERM U1163; Institut Imagine; Paris France
| |
Collapse
|
11
|
Tauber M, Viguier M, Le Gall C, Smahi A, Bachelez H. Is it relevant to use an interleukin-1-inhibiting strategy for the treatment of patients with deficiency of interleukin-36 receptor antagonist? Br J Dermatol 2015; 170:1198-9. [PMID: 24641215 DOI: 10.1111/bjd.12805] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- M Tauber
- Department of Genetics, INSERM U781, Imagine Institute, 24 boulevard Montparnasse, 75015, Paris, France; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Sorbonne Paris Cité Université Paris Diderot, Paris, France
| | | | | | | | | |
Collapse
|
12
|
Tauber M, Viguier M, Alimova E, Petit A, Lioté F, Smahi A, Bachelez H. Partial clinical response to anakinra in severe palmoplantar pustular psoriasis. Br J Dermatol 2014; 171:646-9. [PMID: 24684162 DOI: 10.1111/bjd.13012] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/25/2014] [Indexed: 01/06/2023]
Abstract
BACKGROUND Palmoplantar pustular psoriasis is a clinical psoriasis variant characterised by a high impact on quality of life and poor response to biologics approved for plaque type psoriasis.The recombinant interleukin-1 (IL-1) receptor antagonist anakinra has been recently used for the treatment of isolated refractory cases of generalised pustular psoriasis with contrasted results. OBJECTIVES To report the clinical response in two patients treated with anakinra as salvage therapy in two patients with severe palmoplantar pustular psoriasis refractory to currently available antipsoriatic systemic therapies. METHODS Anakinra was given subcutaneously at the daily dose of 100 mg, and clinical response was evaluated using the palmoplantar psoriasis area and severity index (PPPASI). RESULTS Only partial and transient responses were observed in both patients, who had to stop anakinra due to lack of efficacy and to side effects. CONCLUSION Anakinra appears to provide only partial clinical improvement in refractory palmoplantar pustular psoriasis. Prospective clinical studies on larger populations are warranted to investigate more accurately both efficacy and safety of IL-1-inhibiting strategies in pustular psoriasis.
Collapse
Affiliation(s)
- M Tauber
- Université Paris Diderot-Sorbonne, Paris Cité, Department of Dermatology, Hôpital Saint-Louis, APHP, 1 avenue Claude-Vellefaux, 75475 Cedex 10, Paris, France; Laboratory of genetics of autoinflammatory diseases, Université Paris Diderot-Sorbonne, Paris Cité, Institut Imagine, Hôpital Necker-Enfants Malades, Paris, France
| | | | | | | | | | | | | |
Collapse
|
13
|
Hadj-Rabia S, Jambou M, Cuzeau C, Bonnefont JP, Smahi A, Bodemer C. Mutations du gène WNT10A, vers un phénotype caractéristique. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
14
|
Cluzeau C, Hadj-Rabia S, Bal E, Clauss F, Munnich A, Bodemer C, Headon D, Smahi A. The EDAR370A allele attenuates the severity of hypohidrotic ectodermal dysplasia caused by EDA gene mutation. Br J Dermatol 2011; 166:678-81. [PMID: 21916884 DOI: 10.1111/j.1365-2133.2011.10620.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
15
|
Marrakchi S, Guigue P, Puel A, Zribi J, Sahbatou M, Bodemer C, Casanova J, Sims J, Turki H, Bachelez H, Smahi A. Mutations dans le gène IL-36Ra responsables du psoriasis pustuleux généralisé. Ann Dermatol Venereol 2011. [DOI: 10.1016/j.annder.2011.09.087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
16
|
Chassaing N, Cluzeau C, Bal E, Guigue P, Vincent MC, Viot G, Ginisty D, Munnich A, Smahi A, Calvas P. Mutations in EDARADD
account for a small proportion of hypohidrotic ectodermal dysplasia cases. Br J Dermatol 2010; 162:1044-8. [DOI: 10.1111/j.1365-2133.2010.09670.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
|
17
|
Clauss F, Chassaing N, Smahi A, Vincent MC, Calvas P, Molla M, Lesot H, Alembik Y, Hadj-Rabia S, Bodemer C, Manière MC, Schmittbuhl M. X-linked and autosomal recessive Hypohidrotic Ectodermal Dysplasia: genotypic-dental phenotypic findings. Clin Genet 2010; 78:257-66. [DOI: 10.1111/j.1399-0004.2010.01376.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
18
|
Bal E, Baala L, Cluzeau C, El Kerch F, Ouldim K, Hadj-Rabia S, Bodemer C, Munnich A, Courtois G, Sefiani A, Smahi A. Autosomal dominant anhidrotic ectodermal dysplasias at the EDARADD locus. Hum Mutat 2007; 28:703-9. [PMID: 17354266 DOI: 10.1002/humu.20500] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Anhidrotic ectodermal dysplasia (EDA) is a disorder of ectodermal differentiation characterized by sparse hair, abnormal or missing teeth, and inability to sweat. X-linked EDA is the most common form, caused by mutations in the EDA gene, which encodes ectodysplasin, a member of the tumor necrosis factor (TNF) family. Autosomal dominant and recessive forms of EDA have been also described and are accounted for by two genes. Mutations in EDAR, encoding a TNF receptor (EDAR) cause both dominant and recessive forms. In addition, mutations in a recently identified gene, EDARADD, encoding EDAR-associated death domain (EDARADD) have been shown to cause autosomal recessive EDA. Here, we report a large Moroccan family with an autosomal dominant EDA. We mapped the disease gene to chromosome 1q42.2-q43, and identified a novel missense mutation in the EDARADD gene (c.335T>G, p.Leu112Arg). Thus, the EDARADD gene accounts for both recessive and dominant EDA. EDAR is activated by its ligand, ectodysplasin, and uses EDARADD to build an intracellular complex and activate nuclear factor kappa B (NF-kB). We compared the functional consequences of the dominant (p.Leu112Arg) and recessive mutation (p.Glu142Lys), which both occurred in the death domain (DD) of EDARADD. We demonstrated that the p.Leu112Arg mutation completely abrogated NF-kB activation, whereas the p.Glu142Lys retained the ability to significantly activate the NF-kB pathway. The p.Leu112Arg mutation is probably a dominant negative form as its cotransfection impaired the wild-type EDARADD's ability to activate NF-kB. Our results confirm that NF-kB activation is impaired in EDA and support the role of EDARADD DD as a downstream effector of EDAR signaling.
Collapse
Affiliation(s)
- E Bal
- INSERM U781 et Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Abstract
The recent identification of genetic diseases (incontinentia pigmenti, anhidrotic ectodermal dysplasia with immunodeficiency and cylindromatosis) resulting from mutations affecting components of the nuclear factor-kappaB (NF-kappaB) signaling pathway provides a unique opportunity to understand the function of NF-kappaB in vivo. Besides confirming the importance of NF-kappaB in innate and acquired immunity or bone mass control, analysis of these diseases has uncovered new critical roles played by this transcription factor in the development and homeostasis of the epidermis and the proper function of lymphatic vessels. In addition, the identified mutations will help understanding at the molecular level how NF-kappaB is activated in response to cell stimulation.
Collapse
Affiliation(s)
- G Courtois
- INSERM U697, Pavillon Bazin, Hôpital Saint-Louis, Paris, France.
| | | |
Collapse
|
20
|
Mégarbané A, Vabres P, Slaba S, Smahi A, Loeys B, Okais N. Linear and whorled nevoid hypermelanosis with bilateral giant cerebral aneurysms. Am J Med Genet 2002; 112:95-8. [PMID: 12239729 DOI: 10.1002/ajmg.10666] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
A 24-year-old woman presented with bilateral giant intracavernous carotid artery aneurysms manifesting as a cavernous sinus syndrome on the left side, and anisocoria, ophthalmic pain, and oculomotor paresis on the left side. Physical examination showed mild hyperextensibility of the metacarpophalangeal joints, amelogenesis imperfecta, and hyperpigmentation following Blaschko lines. Analysis of the NEMO gene for incontinentia pigmenti syndrome and of collagen III for Ehlers-Danlos type IV was normal. Skewed X-inactivation patterns in blood lymphocytes were detected. To the best of our knowledge, this association of linear hyperpigmentation and cerebral aneurysms has never been previously reported.
Collapse
Affiliation(s)
- A Mégarbané
- Unité de Génétique Médicale, Faculté de Médecine, Université Saint-Joseph, Beirut, Lebanon
| | | | | | | | | | | |
Collapse
|
21
|
Hadj-Rabia S, Smahi A, Bodemer C. [Anhidrotic ectodermal dysplasia and Incontinentia pigmenti: pieces of the same puzzle]. Ann Dermatol Venereol 2002; 129:277-80. [PMID: 11988680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
|
22
|
Kenwrick S, Woffendin H, Jakins T, Shuttleworth SG, Mayer E, Greenhalgh L, Whittaker J, Rugolotto S, Bardaro T, Esposito T, D'Urso M, Soli F, Turco A, Smahi A, Hamel-Teillac D, Lyonnet S, Bonnefont JP, Munnich A, Aradhya S, Kashork CD, Shaffer LG, Nelson DL, Levy M, Lewis RA. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am J Hum Genet 2001; 69:1210-7. [PMID: 11673821 PMCID: PMC1235532 DOI: 10.1086/324591] [Citation(s) in RCA: 93] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2001] [Accepted: 09/26/2001] [Indexed: 11/03/2022] Open
Abstract
Incontinentia pigmenti (IP), or "Bloch-Sulzberger syndrome," is an X-linked dominant disorder characterized by abnormalities of skin, teeth, hair, and eyes; skewed X-inactivation; and recurrent miscarriages of male fetuses. IP results from mutations in the gene for NF-kappaB essential modulator (NEMO), with deletion of exons 4-10 of NEMO accounting for >80% of new mutations. Male fetuses inheriting this mutation and other "null" mutations of NEMO usually die in utero. Less deleterious mutations can result in survival of males subjects, but with ectodermal dysplasia and immunodeficiency. Male patients with skin, dental, and ocular abnormalities typical of those seen in female patients with IP (without immunodeficiency) are rare. We investigated four male patients with clinical hallmarks of IP. All four were found to carry the deletion normally associated with male lethality in utero. Survival in one patient is explained by a 47,XXY karyotype and skewed X inactivation. Three other patients possess a normal 46,XY karyotype. We demonstrate that these patients have both wild-type and deleted copies of the NEMO gene and are therefore mosaic for the common mutation. Therefore, the repeat-mediated rearrangement leading to the common deletion does not require meiotic division. Hypomorphic alleles, a 47,XXY karyotype, and somatic mosaicism therefore represent three mechanisms for survival of males carrying a NEMO mutation.
Collapse
|
23
|
Siffroi JP, Benzacken B, Angelopoulou R, Le Bourhis C, Berthaut I, Kanafani S, Smahi A, Wolf JP, Dadoune JP. Alternative centromeric inactivation in a pseudodicentric t(Y;13)(q12;p11.2) translocation chromosome associated with extreme oligozoospermia. J Med Genet 2001; 38:802-6. [PMID: 11732493 PMCID: PMC1734752 DOI: 10.1136/jmg.38.11.802] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
24
|
|
25
|
Aradhya S, Woffendin H, Jakins T, Bardaro T, Esposito T, Smahi A, Shaw C, Levy M, Munnich A, D'Urso M, Lewis RA, Kenwrick S, Nelson DL. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet 2001; 10:2171-9. [PMID: 11590134 DOI: 10.1093/hmg/10.19.2171] [Citation(s) in RCA: 141] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Incontinentia pigmenti (IP) is an X-linked dominant disorder characterized by abnormal skin pigmentation, retinal detachment, anodontia, alopecia, nail dystrophy and central nervous system defects. This disorder segregates as a male lethal disorder and causes skewed X-inactivation in female patients. IP is caused by mutations in a gene called NEMO, which encodes a regulatory component of the IkappaB kinase complex required to activate the NF-kappaB pathway. Here we report the identification of 277 mutations in 357 unrelated IP patients. An identical genomic deletion within NEMO accounted for 90% of the identified mutations. The remaining mutations were small duplications, substitutions and deletions. Nearly all NEMO mutations caused frameshift and premature protein truncation, which are predicted to eliminate NEMO function and cause cell lethality. Examination of families transmitting the recurrent deletion revealed that the rearrangement occurred in the paternal germline in most cases, indicating that it arises predominantly by intrachromosomal misalignment during meiosis. Expression analysis of human and mouse NEMO/Nemo showed that the gene becomes active early during embryogenesis and is expressed ubiquitously. These data confirm the involvement of NEMO in IP and will help elucidate the mechanism underlying the manifestation of this disorder and the in vivo function of NEMO. Based on these and other recent findings, we propose a model to explain the pathogenesis of this complex disorder.
Collapse
Affiliation(s)
- S Aradhya
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Döffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, Wood P, Rabia SH, Headon DJ, Overbeek PA, Le Deist F, Holland SM, Belani K, Kumararatne DS, Fischer A, Shapiro R, Conley ME, Reimund E, Kalhoff H, Abinun M, Munnich A, Israël A, Courtois G, Casanova JL. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001; 27:277-85. [PMID: 11242109 DOI: 10.1038/85837] [Citation(s) in RCA: 682] [Impact Index Per Article: 29.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
The molecular basis of X-linked recessive anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) has remained elusive. Here we report hypomorphic mutations in the gene IKBKG in 12 males with EDA-ID from 8 kindreds, and 2 patients with a related and hitherto unrecognized syndrome of EDA-ID with osteopetrosis and lymphoedema (OL-EDA-ID). Mutations in the coding region of IKBKG are associated with EDA-ID, and stop codon mutations, with OL-EDA-ID. IKBKG encodes NEMO, the regulatory subunit of the IKK (IkappaB kinase) complex, which is essential for NF-kappaB signaling. Germline loss-of-function mutations in IKBKG are lethal in male fetuses. We show that IKBKG mutations causing OL-EDA-ID and EDA-ID impair but do not abolish NF-kappaB signaling. We also show that the ectodysplasin receptor, DL, triggers NF-kappaB through the NEMO protein, indicating that EDA results from impaired NF-kappaB signaling. Finally, we show that abnormal immunity in OL-EDA-ID patients results from impaired cell responses to lipopolysaccharide, interleukin (IL)-1beta, IL-18, TNFalpha and CD154. We thus report for the first time that impaired but not abolished NF-kappaB signaling in humans results in two related syndromes that associate specific developmental and immunological defects.
Collapse
Affiliation(s)
- R Döffinger
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Faculté de Médecine Necker-Enfants Malades, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Aradhya S, Ahobila P, Lewis RA, Nelson DL, Esposito T, Ciccodicola A, Bardaro T, D'Urso M, Woffendin H, Kenwrick S, Smahi A, Heuertz S, Munnich A, Heiss NS, Poustka A, Chishti AH. Filamin (FLN1), plexin (SEX), major palmitoylated protein p55 (MPP1), and von-Hippel Lindau binding protein (VBP1) are not involved in incontinentia pigmenti type 2. Am J Med Genet 2000; 94:79-84. [PMID: 10982489 DOI: 10.1002/1096-8628(20000904)94:1<79::aid-ajmg17>3.0.co;2-m] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- S Aradhya
- Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Smahi A, Courtois G, Vabres P, Yamaoka S, Heuertz S, Munnich A, Israël A, Heiss NS, Klauck SM, Kioschis P, Wiemann S, Poustka A, Esposito T, Bardaro T, Gianfrancesco F, Ciccodicola A, D'Urso M, Woffendin H, Jakins T, Donnai D, Stewart H, Kenwrick SJ, Aradhya S, Yamagata T, Levy M, Lewis RA, Nelson DL. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 2000; 405:466-72. [PMID: 10839543 DOI: 10.1038/35013114] [Citation(s) in RCA: 481] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Familial incontinentia pigmenti (IP; MIM 308310) is a genodermatosis that segregates as an X-linked dominant disorder and is usually lethal prenatally in males. In affected females it causes highly variable abnormalities of the skin, hair, nails, teeth, eyes and central nervous system. The prominent skin signs occur in four classic cutaneous stages: perinatal inflammatory vesicles, verrucous patches, a distinctive pattern of hyperpigmentation and dermal scarring. Cells expressing the mutated X chromosome are eliminated selectively around the time of birth, so females with IP exhibit extremely skewed X-inactivation. The reasons for cell death in females and in utero lethality in males are unknown. The locus for IP has been linked genetically to the factor VIII gene in Xq28 (ref. 3). The gene for NEMO (NF-kappaB essential modulator)/IKKgamma (IkappaB kinase-gamma) has been mapped to a position 200 kilobases proximal to the factor VIII locus. NEMO is required for the activation of the transcription factor NF-kappaB and is therefore central to many immune, inflammatory and apoptotic pathways. Here we show that most cases of IP are due to mutations of this locus and that a new genomic rearrangement accounts for 80% of new mutations. As a consequence, NF-kappaB activation is defective in IP cells.
Collapse
Affiliation(s)
- A Smahi
- Department of Genetics, Unité de Recherches sur les Handicaps Génétiques de l'Enfant INSERMU-393, Hopital Necker-Enfants Malades, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Aradhya S, Nelson DL, Heiss NS, Poustka A, Woffendin H, Kenwrick S, Esposito T, Ciccodicola A, Bardaro T, D'Urso M, Smahi A, Munnich A, Herman GE, Lewis RA. Human homologue of the murine bare patches/striated gene is not mutated in incontinentia pigmenti type 2. Am J Med Genet 2000; 91:241-4. [PMID: 10756353 DOI: 10.1002/(sici)1096-8628(20000320)91:3<241::aid-ajmg19>3.0.co;2-j] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
30
|
Heiss NS, Poustka A, Knight SW, Aradhya S, Nelson DL, Lewis RA, Esposito T, Ciccodicola A, D'Urso M, Smahi A, Heuertz S, Munnich A, Vabres P, Woffendin H, Kenwrick S. Mutation analysis of the DKC1 gene in incontinentia pigmenti. J Med Genet 1999; 36:860-2. [PMID: 10636732 PMCID: PMC1734257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
|
31
|
Cabot A, Rozet JM, Gerber S, Perrault I, Ducroq D, Smahi A, Souied E, Munnich A, Kaplan J. A gene for X-linked idiopathic congenital nystagmus (NYS1) maps to chromosome Xp11.4-p11.3. Am J Hum Genet 1999; 64:1141-6. [PMID: 10090899 PMCID: PMC1377838 DOI: 10.1086/302324] [Citation(s) in RCA: 59] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Congenital nystagmus (CN) is a common oculomotor disorder (frequency of 1/1,500 live births) characterized by bilateral uncontrollable ocular oscillations, with onset typically at birth or within the first few months of life. This condition is regarded as idiopathic, after exclusion of nervous and ocular diseases. X-linked, autosomal dominant, and autosomal recessive modes of inheritance have been reported, but X-linked inheritance is probably the most common. In this article, we report the mapping of a gene for X-linked dominant CN (NYS1) to the short arm of chromosome X, by showing close linkage of NYS1 to polymorphic markers on chromosome Xp11.4-p11.3 (maximum LOD score of 3.20, over locus DXS993). Because no candidate gene, by virtue of its function, has been found in this region of chromosome Xp, further studies are required, to reduce the genetic interval encompassing the NYS1 gene. It is hoped that the complete gene characterization will address the complex pathophysiology of CN.
Collapse
Affiliation(s)
- A Cabot
- Unité de Recherches sur les Handicaps Génétiques de l'Enfant, Institut National de la Santé et de la Recherche Médicale U393, Hôpital des Enfants Malades, Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Odent S, Le Marec B, Smahi A, Hors-Cayla C, Milon J, Jouan H, Laurent MC, Borg AM. [Spontaneous abortion of male fetuses with incontinentia pigmenti (apropos of a family)]. J Gynecol Obstet Biol Reprod (Paris) 1998; 26:633-6. [PMID: 9453982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
We report a family with incontinentia pigmenti. One affected woman had seven pregnancies, seven miscarriages; a prenatal diagnosis by molecular biology was undertaken in the last four cases (two males, two females). In the last two males, a miscarriage occurred at the beginning of the second trimester with cystic hygroma in a case. In the first two males a miscarriage was observed also at the beginning of the second trimester after chorionic biopsy or amniocentesis. These two miscarriages would not be a complication of prenatal diagnosis but spontaneous abortion of an affected male. The date of the miscarriage of affected males (the beginning of the second trimester) and the role of a cystic hygroma for the diagnosis of incontinentia pigmenti in this mother of a fetus karyotyped 46,XY are discussed.
Collapse
Affiliation(s)
- S Odent
- Unité de Médecine Foetale, Hôpital Pontchaillou, Rennes
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Heuertz S, Smahi A, Wilkie AO, Le Merrer M, Maroteaux P, Hors-Cayla MC. Genetic mapping of Xp22.12-p22.31, with a refined localization for spondyloepiphyseal dysplasia (SEDL). Hum Genet 1995; 96:407-10. [PMID: 7557961 DOI: 10.1007/bf00191797] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Spondyloepiphyseal dysplasia tarda (SEDL) is an X-linked recessive disorder characterized in affected males by short stature resulting from a growth defect of the vertebral bodies. We have extended our earlier studies by analyzing 15 families with newly identified microsatellite DNA markers; analysis of recombination events with these markers indicates that the gene responsible for SEDL is located in Xp22 between DXS 16 and DXS 987 on an interval spanning approximately 2 Mb.
Collapse
Affiliation(s)
- S Heuertz
- Inserm U 393, Hôpital Necker-Enfants Malades, Paris, France
| | | | | | | | | | | |
Collapse
|
34
|
Heuertz S, Smahi A, Sanak M, Holvoet-Vermaut L, Hors-Cayla MC. Fine deletion mapping of the p22 region of the human X chromosome using a radiation-induced hybrid panel. Cytogenet Cell Genet 1995; 69:7-10. [PMID: 7835091 DOI: 10.1159/000133926] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Radiation-induced somatic cell hybrids containing fragments of the human X chromosome were constructed. A panel of 17 hybrids was selected with the help of known markers in the Xp22 region. These hybrids identified 11 different breakpoints between Xp22.2 and Xp21.3. Eight markers were located in eight of the nine corresponding intervals, resulting in the following physical map: tel...DXS89-DXS278-DXS85-(DXS1224, DXS16)-(GLRA2, DXS987)-DXS207-(DXS-197, DXS1053)-(DXS43, DXS1195)-(DXS1229, DXS-999)-(DXS1052, DXS92, DXS274)-(DXS41, DXS1226)-DXS1198-DXS28...cen.
Collapse
Affiliation(s)
- S Heuertz
- INSERM U 393, Hôpital Necker-Enfants Malades, Paris, France
| | | | | | | | | |
Collapse
|
35
|
Smahi A, Hyden-Granskog C, Peterlin B, Vabres P, Heuertz S, Fulchignoni-Lataud MC, Dahl N, Labrune P, Le Marec B, Piussan C. The gene for the familial form of incontinentia pigmenti (IP2) maps to the distal part of Xq28. Hum Mol Genet 1994; 3:273-8. [PMID: 8004094 DOI: 10.1093/hmg/3.2.273] [Citation(s) in RCA: 53] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
Linkage data for familial incontinentia pigmenti (IP2) and 17 X chromosomal markers are reported. The linkage previously found between IP2 and the F8C locus is confirmed (Z max = 11.85 at theta = 0.028). Linkage is established with distal markers DXS1108 (Z max = 10.06 at theta = 0.00) and DXYS154 (Z = 9.07 at theta = 0.019). Multipoint analysis supports the distal localization of the IP2 gene with respect to the F8C locus.
Collapse
Affiliation(s)
- A Smahi
- Unité de Recherches sur les Handicaps Génétiquesde l'Enfant, INSERM U. 12, Hôpital Necker-Enfants Malades, Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Peterlin B, Smahi A, Holvoet-Vermaut L, Heitz D, Dahl N, Hors-Cayla MC. An irradiation-reduced hybrid panel for fine-structure mapping of the Xq28 region in the human genome. Cytogenet Cell Genet 1993; 62:58-9. [PMID: 8422759 DOI: 10.1159/000133447] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Irradiation-reduced somatic cell hybrids containing fragments of the human X chromosome were constructed. Analysis of 16 hybrids that retained the Xq28 region with 12 Xq28-specific markers identified at least six different breakpoints, supporting the order cen-DXS304-DXS374-(DXS33, DXS134, DXS52, DXS15)-RCP-(DXS254, G6PD, F8C)-(DXS115, DXYS64)-qter. The generated panel of hybrids provides a useful tool for fine mapping of probes in the Xq28 region.
Collapse
Affiliation(s)
- B Peterlin
- INSERM U-12, Hôpital des Enfants-Malades, Paris France
| | | | | | | | | | | |
Collapse
|